Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Heal Capital is a venture capital firm founded in 2019 and headquartered in Berlin, Germany. The firm focuses on investing in HealthTech startups across Europe, aiming to redefine healthcare through technology. With a total AUM exceeding €200 million, Heal Capital has established itself as a significant player in the European venture capital landscape.
The firm closed its first fund, Heal Capital Fund I, at €100 million in January 2021, backed by over 25 German private health insurers, including Allianz, AXA, and DKV. This unique LP base provides Heal Capital with strategic alignment and direct access to healthcare distribution channels, enhancing the growth potential of its portfolio companies.
Heal Capital has evaluated over 27 portfolio companies from a pool of more than 8,000 ventures, demonstrating its rigorous selection process. The firm is recognized as a leading European HealthTech and AI venture capital fund, focusing on mission-driven founders and innovative solutions in the healthcare sector.
Heal Capital invests exclusively in HealthTech startups, targeting companies at the Pre-Seed to Series A stages. The firm typically provides capital ranging from €1 million to €5 million, ensuring that founders have the necessary resources to develop and scale their innovative healthcare solutions. The investment strategy emphasizes the convergence of healthcare and technology, with a strong focus on mission-driven founders.
The firm seeks startups that are innovating in sectors such as healthcare, artificial intelligence, and digital health. Heal Capital's investment thesis highlights the importance of strategic alignment with health insurers, which allows portfolio companies to gain direct access to distribution channels and operational expertise. This approach not only enhances the growth potential of the startups but also fosters collaboration within the healthcare ecosystem.
Heal Capital's portfolio includes a diverse range of HealthTech companies, showcasing its commitment to innovation in the sector. Notable portfolio companies include:
These companies represent Heal Capital's focus on mission-driven innovation in healthcare, with a total of 27 evaluated portfolio companies.
Eckhardt Weber: Founding Managing Partner with a background as MD at finleap and Heartbeat Labs, specializing in the European fintech and digital health sectors.
Christian Lautner: Founding Managing Partner with extensive experience in venture capital and a focus on HealthTech investments.
Marta Mrozowicz: Member of the Investment Team, contributing expertise in evaluating HealthTech startups.
Cecilia von Oldershausen: Responsible for Finance and Operations, ensuring the firm's financial health and operational efficiency.
Dr. Lucas Mittelmeier: Investment Team member with a focus on identifying promising HealthTech ventures.
Dr. Vahid Asimi: Investment Team member, bringing expertise in healthcare innovation and technology.
Felix Nizet: Investment Team member, contributing to the evaluation and support of portfolio companies.
Dr. Markus Müschenich: Founding Partner with a strong background in venture capital and healthcare.
Peter Wibbe: Venture Partner, providing strategic insights and connections within the healthcare sector.
Hana Besbes: Venture Partner with expertise in HealthTech investments and startup growth.
Dr. Christian Weiss: Managing Partner with prior experience at Creathor Venture and AlixPartners, focusing on HealthTech and AI.
To pitch to Heal Capital, founders should use the submission link provided on their website. It is important to include a detailed pitch deck that outlines the business model, market opportunity, and team qualifications. Founders should expect a response within a reasonable timeframe, typically within a few weeks.
Warm introductions are preferred, as they can facilitate a more favorable review process. However, direct submissions through the website are also accepted.
In January 2021, Heal Capital closed its first fund, Heal Capital Fund I, at €100 million, marking a significant milestone for the firm. This fund is backed by over 25 German private health insurers, providing a unique strategic advantage in the HealthTech sector.
Recently, Heal Capital has made notable investments in companies such as Siilo, an Amsterdam-based medical messaging platform, Infermedica, an AI-driven triage and symptom checker from Poland, and Ceregate, a Munich-based company specializing in computer-brain interface technology.
As of 2023, Heal Capital has evaluated over 27 portfolio companies from a pool of more than 8,000 ventures, demonstrating its active role in the European HealthTech investment landscape.
What are Heal Capital's investment criteria?
Heal Capital invests in HealthTech startups at the Pre-Seed to Series A stages, focusing on mission-driven founders. The firm typically provides capital ranging from €1 million to €5 million.
How can I apply or pitch to Heal Capital?
Founders can submit their pitch through the provided submission link on Heal Capital's website. It is recommended to include a comprehensive overview of the business model, market opportunity, and team background in the pitch deck.
What makes Heal Capital different from other venture capital firms?
Heal Capital's unique positioning comes from its strong ties to over 25 German private health insurers, providing portfolio companies with direct access to distribution channels and operational expertise in the healthcare sector.
What is Heal Capital's geographic scope?
The firm primarily invests in HealthTech startups across Europe, focusing on companies that are innovating in the healthcare space.
What is Heal Capital's post-investment involvement like?
Heal Capital offers strategic support through its extensive network of health insurers, which can help portfolio companies navigate the healthcare market and enhance their growth potential.
What is the typical check size for investments?
Heal Capital typically invests between €1 million and €5 million in each startup, depending on the stage and needs of the company.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.